.:. Browse > Domain list > Immunotherapy .:.

3 documents ordered by : Date Title first author name document type Submit date

Cutting edge: CD4-independent development of functional FoxP3+ regulatory t cells. Blache C., ADRIOUCH S., Calbo S., Drouot L., Dulauroy S., Arnoult C., Le Corre S., Six A., Seman M., Boyer O. J Immunol 183, 7 (2009) 4182-6 [hal-00420220 - version 1]

Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer. Lemoine F. M., Cherai M., Giverne C., Dimitri D., Rosenzwajg M., Trebeden-Negre H., Chaput N., Barrou B., Thioun N., Gattegnio B. et al International journal of oncology 35, 3 (2009) 569-81 [hal-00420217 - version 1]

Clinical grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene: authors' reponse. Guillot-Delost M., Cheraï M., Hamel Y., Rosenzwajg M., Baillou C., Simonin G., Leclercq V., Mariotti-Ferrandiz M. E., Six A., Bon-Durand V. et al The Journal of Gene Medicine 11, 8 (2009) 737-8 [hal-00420219 - version 1]